Canton Hathaway’s Bio-Techne TECH Stock Holding History

Canton Hathaway’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,936	Closed	-$120K	–	330
2020 Q3	$120K	Buy	+1,936	New	+$126K	0.05%	149

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canton Hathaway's TECH Position: Q4 2020 in Review

Canton Hathaway sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 1,936 shares — an estimated $120K sold.

Canton Hathaway first reported a position in TECH in Q3 2020 and held it in 1 quarter. The position peaked at $120K in Q3 2020. 440 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

Canton Hathaway reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
Canton Hathaway sold 1,936 Bio-Techne shares in Q4 2020, an estimated $120K.
Canton Hathaway first reported a position in Bio-Techne in Q3 2020 and held it in 1 quarter.
Canton Hathaway's Bio-Techne position peaked at $120K in Q3 2020.
440 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Canton Hathaway's 13F filing for Q4 2020, filed 3 Feb 2021.